By Andrew McDougall+, 03-Jun-2015, please follow the link to Cosmetics Designs.com USA for complete article
Related topics: Skin Care, Formulation & Science
Consumer goods giant Procter & Gamble is following its rivals down the 3D skin printing road as it looks to fund
a five year research project to develop a commercial process for making three-dimensional printed skin tissue.
Last month we reported that L’Oreal had joined forces with a 3D human tissue company gaining the exclusive right to use the skin tissue models developed by Organovo for the “development, manufacturing, testing, evaluation and sale ofnon-prescription cosmetic, beauty, dermatology and skin care products.”
Now, P&G announces that it wants to be able to use artificial skin developed in a similar way to test the efficacy and toxicity of its new products, including those for its beauty care business.
“We want to look at the possibilities of bioprinting. It’s definitely a very strong emerging area,” says Professor Elena Lurie-Luke, the head of P&G’s Global Life Sciences Open Innovation business.
“We have a number of different in vitro skin models we’re working on because we are very involved in beauty care. If companies are doing innovation and interested in new tools then bioprinting should very much be on their horizon.”
please follow the link to Cosmetics Designs.com USA for complete article
P&G sets off on 3D bioprinted skin research project http://www.cosmeticsdesign.com/content/view/print/1126836